| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 STAB2 PNLIPRP2 FAT3 PCLO SYT6 ADGRV1 CLSTN1 SYT10 CELSR3 CELSR2 HMCN1 VCAN MACF1 EGFLAM DNASE1L3 | 3.58e-05 | 749 | 132 | 16 | GO:0005509 |
| GeneOntologyCellularComponent | presynaptic active zone | 3.87e-05 | 141 | 136 | 7 | GO:0048786 | |
| GeneOntologyCellularComponent | synaptic membrane | HIP1 NAPEPLD HCN1 SYT6 NBEA CLSTN1 OPRK1 MET CELSR3 TENM3 KCNJ4 BSN GABRR3 | 1.14e-04 | 583 | 136 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | postsynaptic membrane | 3.25e-04 | 405 | 136 | 10 | GO:0045211 | |
| Domain | EGF_1 | STAB2 ADAM21 FAT3 ADAM30 ITGB8 CELSR3 CELSR2 HMCN1 TENM3 VCAN EGFLAM MUC4 TNXB | 2.22e-08 | 255 | 128 | 13 | PS00022 |
| Domain | EGF-like_CS | STAB2 ADAM21 FAT3 ADAM30 ITGB8 CELSR3 CELSR2 HMCN1 TENM3 VCAN EGFLAM MUC4 TNXB | 2.92e-08 | 261 | 128 | 13 | IPR013032 |
| Domain | EGF_2 | STAB2 ADAM21 FAT3 ADAM30 ITGB8 CELSR3 CELSR2 HMCN1 TENM3 VCAN EGFLAM MUC4 TNXB | 3.49e-08 | 265 | 128 | 13 | PS01186 |
| Domain | EGF_3 | STAB2 ADAM21 FAT3 ADAM30 CELSR3 CELSR2 HMCN1 TENM3 VCAN EGFLAM MUC4 TNXB | 7.80e-08 | 235 | 128 | 12 | PS50026 |
| Domain | EGF-like_dom | STAB2 ADAM21 FAT3 ADAM30 CELSR3 CELSR2 HMCN1 TENM3 VCAN EGFLAM MUC4 TNXB | 1.46e-07 | 249 | 128 | 12 | IPR000742 |
| Domain | EGF | STAB2 FAT3 ITGB8 CELSR3 CELSR2 HMCN1 TENM3 VCAN EGFLAM MUC4 TNXB | 6.62e-07 | 235 | 128 | 11 | SM00181 |
| Domain | EGF | 2.49e-06 | 126 | 128 | 8 | PF00008 | |
| Domain | - | 4.03e-06 | 95 | 128 | 7 | 2.60.120.200 | |
| Domain | EGF_CA | 2.10e-05 | 122 | 128 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.33e-05 | 124 | 128 | 7 | IPR001881 | |
| Domain | Znf_piccolo | 4.66e-05 | 2 | 128 | 2 | IPR008899 | |
| Domain | zf-piccolo | 4.66e-05 | 2 | 128 | 2 | PF05715 | |
| Domain | LAM_G_DOMAIN | 1.30e-04 | 38 | 128 | 4 | PS50025 | |
| Domain | ConA-like_dom | 1.35e-04 | 219 | 128 | 8 | IPR013320 | |
| Domain | Elf-1_N | 1.39e-04 | 3 | 128 | 2 | PF12310 | |
| Domain | TF_Elf_N | 1.39e-04 | 3 | 128 | 2 | IPR022084 | |
| Domain | Laminin_G_2 | 1.59e-04 | 40 | 128 | 4 | PF02210 | |
| Domain | Cadherin | 1.62e-04 | 118 | 128 | 6 | IPR002126 | |
| Domain | LamG | 2.31e-04 | 44 | 128 | 4 | SM00282 | |
| Domain | Synaptotagmin | 3.29e-04 | 20 | 128 | 3 | IPR001565 | |
| Domain | ASX_HYDROXYL | 6.26e-04 | 100 | 128 | 5 | PS00010 | |
| Domain | Laminin_G | 6.71e-04 | 58 | 128 | 4 | IPR001791 | |
| Domain | EGF_extracell | 7.63e-04 | 60 | 128 | 4 | IPR013111 | |
| Domain | EGF_2 | 7.63e-04 | 60 | 128 | 4 | PF07974 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.15e-04 | 106 | 128 | 5 | IPR000152 | |
| Domain | AT_hook | 8.15e-04 | 27 | 128 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 8.15e-04 | 27 | 128 | 3 | IPR017956 | |
| Domain | ETS_DOMAIN_1 | 9.09e-04 | 28 | 128 | 3 | PS00345 | |
| Domain | ETS_DOMAIN_2 | 9.09e-04 | 28 | 128 | 3 | PS00346 | |
| Domain | Ets | 9.09e-04 | 28 | 128 | 3 | PF00178 | |
| Domain | ETS | 9.09e-04 | 28 | 128 | 3 | SM00413 | |
| Domain | Ets_dom | 9.09e-04 | 28 | 128 | 3 | IPR000418 | |
| Domain | ETS_DOMAIN_3 | 9.09e-04 | 28 | 128 | 3 | PS50061 | |
| Domain | CADHERIN_1 | 1.09e-03 | 113 | 128 | 5 | PS00232 | |
| Domain | Cadherin | 1.09e-03 | 113 | 128 | 5 | PF00028 | |
| Domain | EGF_LAM_2 | 1.11e-03 | 30 | 128 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.11e-03 | 30 | 128 | 3 | PS01248 | |
| Domain | CADHERIN_2 | 1.13e-03 | 114 | 128 | 5 | PS50268 | |
| Domain | - | 1.13e-03 | 114 | 128 | 5 | 2.60.40.60 | |
| Domain | CA | 1.18e-03 | 115 | 128 | 5 | SM00112 | |
| Domain | Cadherin-like | 1.22e-03 | 116 | 128 | 5 | IPR015919 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.27e-03 | 8 | 128 | 2 | IPR019565 | |
| Domain | Calx_beta | 1.27e-03 | 8 | 128 | 2 | SM00237 | |
| Domain | Thiol-ester_cl | 1.27e-03 | 8 | 128 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 1.27e-03 | 8 | 128 | 2 | IPR019742 | |
| Domain | A2M_N_2 | 1.27e-03 | 8 | 128 | 2 | SM01359 | |
| Domain | - | 1.27e-03 | 8 | 128 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 1.27e-03 | 8 | 128 | 2 | SM01361 | |
| Domain | A2M | 1.27e-03 | 8 | 128 | 2 | SM01360 | |
| Domain | GPS | 1.61e-03 | 34 | 128 | 3 | SM00303 | |
| Domain | Calx_beta | 1.63e-03 | 9 | 128 | 2 | IPR003644 | |
| Domain | Calx-beta | 1.63e-03 | 9 | 128 | 2 | PF03160 | |
| Domain | EGF_Lam | 1.75e-03 | 35 | 128 | 3 | SM00180 | |
| Domain | GPS | 1.75e-03 | 35 | 128 | 3 | PF01825 | |
| Domain | GPS | 1.90e-03 | 36 | 128 | 3 | PS50221 | |
| Domain | - | JAML NCR3LG1 MET HMCN1 VCAN VSIG10L KIRREL1 ROS1 EGFLAM FCRL5 TAPBP TNXB | 2.02e-03 | 663 | 128 | 12 | 2.60.40.10 |
| Domain | A2M | 2.02e-03 | 10 | 128 | 2 | PF00207 | |
| Domain | A2M_N_2 | 2.02e-03 | 10 | 128 | 2 | IPR011625 | |
| Domain | A2M_comp | 2.02e-03 | 10 | 128 | 2 | IPR011626 | |
| Domain | Rap_GAP | 2.02e-03 | 10 | 128 | 2 | PF02145 | |
| Domain | A2M_recep | 2.02e-03 | 10 | 128 | 2 | PF07677 | |
| Domain | A2M_comp | 2.02e-03 | 10 | 128 | 2 | PF07678 | |
| Domain | A2M_N | 2.02e-03 | 10 | 128 | 2 | PF01835 | |
| Domain | A2M_N | 2.02e-03 | 10 | 128 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.02e-03 | 10 | 128 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.02e-03 | 10 | 128 | 2 | PS00477 | |
| Domain | A2M_N_2 | 2.02e-03 | 10 | 128 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 2.02e-03 | 10 | 128 | 2 | IPR001599 | |
| Domain | GPS | 2.06e-03 | 37 | 128 | 3 | IPR000203 | |
| Domain | Laminin_EGF | 2.23e-03 | 38 | 128 | 3 | IPR002049 | |
| Domain | aa-tRNA-synt_IIb | 2.46e-03 | 11 | 128 | 2 | IPR002314 | |
| Domain | Rap_GAP_dom | 2.46e-03 | 11 | 128 | 2 | IPR000331 | |
| Domain | GFP-like | 2.46e-03 | 11 | 128 | 2 | IPR023413 | |
| Domain | - | 2.46e-03 | 11 | 128 | 2 | 3.40.50.800 | |
| Domain | - | 2.46e-03 | 11 | 128 | 2 | 2.40.155.10 | |
| Domain | GAIN_dom_N | 2.46e-03 | 11 | 128 | 2 | IPR032471 | |
| Domain | RAPGAP | 2.46e-03 | 11 | 128 | 2 | PS50085 | |
| Domain | tRNA-synt_2b | 2.46e-03 | 11 | 128 | 2 | PF00587 | |
| Domain | GAIN | 2.46e-03 | 11 | 128 | 2 | PF16489 | |
| Domain | GPCR_2_extracellular_dom | 2.58e-03 | 40 | 128 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 2.58e-03 | 40 | 128 | 3 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 2.58e-03 | 40 | 128 | 3 | PS50227 | |
| Domain | WD40_repeat | 2.72e-03 | 272 | 128 | 7 | IPR001680 | |
| Domain | - | 2.94e-03 | 12 | 128 | 2 | 1.50.10.20 | |
| Domain | WD_REPEATS_1 | 3.07e-03 | 278 | 128 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 3.14e-03 | 279 | 128 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 3.14e-03 | 279 | 128 | 7 | PS50294 | |
| Domain | Ig-like_fold | JAML NCR3LG1 MET HMCN1 VCAN VSIG10L KIRREL1 ROS1 EGFLAM FCRL5 TAPBP TNXB | 3.37e-03 | 706 | 128 | 12 | IPR013783 |
| Domain | Link_dom | 3.46e-03 | 13 | 128 | 2 | IPR000538 | |
| Domain | Xlink | 3.46e-03 | 13 | 128 | 2 | PF00193 | |
| Domain | LINK_2 | 3.46e-03 | 13 | 128 | 2 | PS50963 | |
| Domain | LINK | 3.46e-03 | 13 | 128 | 2 | SM00445 | |
| Domain | LINK_1 | 3.46e-03 | 13 | 128 | 2 | PS01241 | |
| Domain | PDZ | 3.86e-03 | 151 | 128 | 5 | PS50106 | |
| Domain | PDZ | 3.97e-03 | 152 | 128 | 5 | IPR001478 | |
| Domain | Anticodon-bd | 4.02e-03 | 14 | 128 | 2 | IPR004154 | |
| Domain | Kinase-like_dom | 4.16e-03 | 542 | 128 | 10 | IPR011009 | |
| Domain | WD40_repeat_dom | 4.41e-03 | 297 | 128 | 7 | IPR017986 | |
| Domain | 7tm_2 | 4.87e-03 | 50 | 128 | 3 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 4.87e-03 | 50 | 128 | 3 | PS00650 | |
| Pubmed | EPRS1 DCHS2 ATP13A1 PPFIBP1 HIPK1 ACO1 HCN1 NBEA SHTN1 TTC3 ITGB8 WDR19 CRYL1 CELSR3 SUPT5H SIPA1L1 MACF1 PRKDC HERC2 MLST8 MVP | 3.45e-08 | 1285 | 137 | 21 | 35914814 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DPYSL3 SLC4A7 PPFIBP1 POTEF PTPN21 SHTN1 FSIP2 SLC38A2 NEK1 ALMS1 SIPA1L1 DOCK7 MACF1 AQR TNS3 AHNAK2 | 3.16e-07 | 861 | 137 | 16 | 36931259 |
| Pubmed | PDS5B HDAC5 HIPK1 GON4L EPG5 TENM3 BAZ2A SIPA1L1 DOCK7 MACF1 AQR | 6.98e-07 | 407 | 137 | 11 | 12693553 | |
| Pubmed | TOR1AIP2 SLC4A7 PPFIBP1 RALGAPA2 PARD6B MET NUP155 CELSR2 TENM3 KIRREL1 MACF1 | 9.71e-07 | 421 | 137 | 11 | 36976175 | |
| Pubmed | 1.19e-06 | 6 | 137 | 3 | 14970218 | ||
| Pubmed | TOR1AIP2 TRAPPC11 ADAM30 NBEA OR52P1 WDR19 TPK1 SLC38A2 CRYL1 COQ8A FLCN BSN AHNAK2 | 1.58e-06 | 638 | 137 | 13 | 31182584 | |
| Pubmed | TOR1AIP2 SLC4A7 DDX31 ATP13A1 PPFIBP1 FAAP20 CHD1 CLPX TTC3 WDR19 SLC38A2 MET NUP155 BAZ2A CIZ1 KIRREL1 MACF1 HERC2 SUCO AQR | 1.61e-06 | 1487 | 137 | 20 | 33957083 | |
| Pubmed | 1.91e-06 | 209 | 137 | 8 | 36779422 | ||
| Pubmed | A2M EPRS1 PPFIBP1 GON4L CLPX CLSTN1 FANCA NUP155 COQ8A SUPT5H DOCK7 EIF2AK4 AQR | 1.94e-06 | 650 | 137 | 13 | 38777146 | |
| Pubmed | PDS5B DDX31 CHD1 NUP155 BAZ2A SUPT5H MKI67 DOCK7 MACF1 PRKDC HERC2 MVP AQR | 2.04e-06 | 653 | 137 | 13 | 22586326 | |
| Pubmed | 3.12e-06 | 101 | 137 | 6 | 10997877 | ||
| Pubmed | 3.31e-06 | 225 | 137 | 8 | 12168954 | ||
| Pubmed | TOR1AIP2 EFL1 DPYSL3 DDX31 NBEA PTPN21 CLPX PTPA NUP155 SUPT5H MKI67 KIRREL1 EIF2AK4 HERC2 HERC1 TNS3 | 4.09e-06 | 1049 | 137 | 16 | 27880917 | |
| Pubmed | A2M HIPK1 E4F1 TTC3 EPG5 MRTFB NUP155 TENM3 SUPT5H MACF1 HERC2 HERC1 | 4.20e-06 | 591 | 137 | 12 | 15231748 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPRS1 DPYSL3 CHD1 TACC2 SHTN1 NEK1 MRTFB ALMS1 BAZ2A CIZ1 MKI67 MACF1 ELF2 PRKDC AHNAK2 | 4.51e-06 | 934 | 137 | 15 | 33916271 |
| Pubmed | TOR1AIP2 EPRS1 SLC4A7 POC1A TACC2 TTC3 SLC38A2 KMT2C COQ8A SIPA1L1 VCAN MACF1 EIF2AK4 HERC1 SUCO TAPBP | 6.17e-06 | 1084 | 137 | 16 | 11544199 | |
| Pubmed | HIP1 SLC4A7 DDX31 ATP13A1 PPFIBP1 GON4L CHD1 E4F1 PARD6B KMT2C MRTFB BAZ2A SIPA1L1 CIZ1 MACF1 HERC2 HEATR5B TAPBP AQR | 6.92e-06 | 1497 | 137 | 19 | 31527615 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 7.00e-06 | 67 | 137 | 5 | 21875946 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | TOR1AIP2 EPRS1 SLC4A7 ATP13A1 CD109 CLPX SUPT5H PRKDC MVP AHNAK2 | 7.25e-06 | 422 | 137 | 10 | 27342126 |
| Pubmed | 1.03e-05 | 347 | 137 | 9 | 17114649 | ||
| Pubmed | EPRS1 DPYSL3 SHTN1 KMT2C NEK1 MRTFB ALMS1 BAZ2A CIZ1 DOCK7 PRKDC | 1.21e-05 | 549 | 137 | 11 | 38280479 | |
| Pubmed | 1.28e-05 | 12 | 137 | 3 | 37935281 | ||
| Pubmed | 1.34e-05 | 130 | 137 | 6 | 12421765 | ||
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 1.54e-05 | 2 | 137 | 2 | 23403927 | |
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 1.54e-05 | 2 | 137 | 2 | 26793095 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 29621589 | ||
| Pubmed | MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity. | 1.54e-05 | 2 | 137 | 2 | 33824309 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 20332206 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 10790539 | ||
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 1.54e-05 | 2 | 137 | 2 | 21935939 | |
| Pubmed | Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial. | 1.54e-05 | 2 | 137 | 2 | 31584608 | |
| Pubmed | Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo. | 1.54e-05 | 2 | 137 | 2 | 25652077 | |
| Pubmed | Histone deacetylase 5 promotes Wilms' tumor cell proliferation through the upregulation of c-Met. | 1.54e-05 | 2 | 137 | 2 | 26847592 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 22396592 | ||
| Pubmed | Characterization of NERF, a novel transcription factor related to the Ets factor ELF-1. | 1.54e-05 | 2 | 137 | 2 | 8756667 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 31361233 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 27321892 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 32493491 | ||
| Pubmed | 1.80e-05 | 469 | 137 | 10 | 27634302 | ||
| Pubmed | 2.11e-05 | 14 | 137 | 3 | 16452088 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TOR1AIP2 DPYSL3 CD109 CLSTN1 ITGB8 FANCA SLC38A2 MET CELSR3 CELSR2 TENM3 FLCN KIRREL1 SUCO TAPBP ADPGK | 2.18e-05 | 1201 | 137 | 16 | 35696571 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DDX31 HDAC5 HIPK1 FAAP20 TACC2 MRTFB ALMS1 SUPT5H MACF1 PLPBP BSN | 2.28e-05 | 588 | 137 | 11 | 38580884 |
| Pubmed | 4.07e-05 | 233 | 137 | 7 | 37704626 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 22923485 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 33402590 | ||
| Pubmed | Analysis of the status of EGFR, ROS1 and MET genes in non-small cell lung adenocarcinoma. | 4.61e-05 | 3 | 137 | 2 | 28952227 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 18768922 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 11677057 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 21940993 | ||
| Pubmed | RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway. | 4.61e-05 | 3 | 137 | 2 | 25751062 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 10531344 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 27136744 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 18449888 | ||
| Pubmed | High-Confidence Interactome for RNF41 Built on Multiple Orthogonal Assays. | 4.61e-05 | 50 | 137 | 4 | 29560723 | |
| Pubmed | Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development. | 4.67e-05 | 18 | 137 | 3 | 33108146 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDS5B EPRS1 DNAH10 ATP13A1 PCLO CHD1 CLPX TTC3 SLC38A2 NUP155 SUPT5H MKI67 DOCK7 PLPBP PRKDC BSN AQR | 4.76e-05 | 1425 | 137 | 17 | 30948266 |
| Pubmed | ADGRV1 WDR19 SLC38A2 KMT2C NUP155 CELSR3 COQ8A EIF2AK4 FAM149B1 BSN | 4.98e-05 | 529 | 137 | 10 | 14621295 | |
| Pubmed | 5.45e-05 | 332 | 137 | 8 | 37433992 | ||
| Pubmed | 5.53e-05 | 19 | 137 | 3 | 31345929 | ||
| Pubmed | SLC4A7 PPFIBP1 NBEA AK8 SLC38A2 MET NUP155 TENM3 MKI67 DOCK7 KIRREL1 PRKDC | 6.19e-05 | 777 | 137 | 12 | 35844135 | |
| Pubmed | Heritability and genetic association analysis of cognition in the Diabetes Heart Study. | 7.55e-05 | 21 | 137 | 3 | 24684796 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | TOR1AIP2 ATP13A1 ACO1 NLRX1 UPK3B SHTN1 SLC38A2 MET PTPA CELSR2 MACF1 PRKDC HERC1 ADPGK | 8.11e-05 | 1061 | 137 | 14 | 33845483 |
| Pubmed | 8.71e-05 | 263 | 137 | 7 | 34702444 | ||
| Pubmed | Pax-3 is necessary for migration but not differentiation of limb muscle precursors in the mouse. | 9.19e-05 | 4 | 137 | 2 | 8631247 | |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 28475179 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 25917546 | ||
| Pubmed | The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms. | 9.19e-05 | 4 | 137 | 2 | 37224017 | |
| Pubmed | Synaptotagmin-3 drives AMPA receptor endocytosis, depression of synapse strength, and forgetting. | 9.19e-05 | 4 | 137 | 2 | 30545844 | |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 22490868 | ||
| Pubmed | Developmental expression profiles of Celsr (Flamingo) genes in the mouse. | 9.19e-05 | 4 | 137 | 2 | 11850187 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TOR1AIP2 PDS5B EPRS1 ATP13A1 CLSTN1 FANCA SLC38A2 NUP155 KIRREL1 PRKDC HEATR5B TAPBP CEP97 | 9.45e-05 | 942 | 137 | 13 | 31073040 |
| Pubmed | Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. | 1.08e-04 | 62 | 137 | 4 | 17975119 | |
| Pubmed | Gene variants associated with ischemic stroke: the cardiovascular health study. | 1.15e-04 | 63 | 137 | 4 | 19023099 | |
| Pubmed | SGIP1 HCN1 DAPK1 NBEA SHTN1 TTC3 CELSR2 KCNJ4 SIPA1L1 DOCK7 MACF1 HERC2 BSN | 1.18e-04 | 963 | 137 | 13 | 28671696 | |
| Pubmed | 1.22e-04 | 64 | 137 | 4 | 22261194 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HIP1 ATP13A1 NLRX1 RALGAPA2 TTC3 FANCA KMT2C CELSR3 CELSR2 FLCN PRKDC HERC2 HERC1 AHNAK2 | 1.24e-04 | 1105 | 137 | 14 | 35748872 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | PDS5B PPFIBP1 DAPK1 CLPX RALGAPA2 FANCA TENM3 MACF1 HERC2 HERC1 TAPBP | 1.37e-04 | 719 | 137 | 11 | 35337019 |
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 39116209 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 16177047 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 10207087 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 27062243 | ||
| Pubmed | Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2. | 1.53e-04 | 5 | 137 | 2 | 16301216 | |
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 22692047 | ||
| Pubmed | ATP13A1 PPFIBP1 RALGAPA2 CLSTN1 PRX NEK1 ALMS1 MACF1 ARHGAP28 | 1.55e-04 | 493 | 137 | 9 | 15368895 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.56e-04 | 202 | 137 | 6 | 33005030 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.56e-04 | 608 | 137 | 10 | 36089195 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.65e-04 | 497 | 137 | 9 | 36774506 | |
| Pubmed | EPRS1 SLC4A7 SGIP1 ATP13A1 HCN1 PCLO NBEA TACC2 MET CELSR2 SIPA1L1 DOCK7 MACF1 BSN | 1.70e-04 | 1139 | 137 | 14 | 36417873 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 1.85e-04 | 621 | 137 | 10 | 22794259 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.90e-04 | 398 | 137 | 8 | 35016035 | |
| Pubmed | TOR1AIP2 PPFIBP1 CD109 CLPX SLC38A2 MET PTPA NUP155 MKI67 MACF1 PRKDC MLST8 TAPBP ADPGK AQR | 1.91e-04 | 1297 | 137 | 15 | 33545068 | |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 1.96e-04 | 400 | 137 | 8 | 35013556 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 2.02e-04 | 212 | 137 | 6 | 33853758 | |
| Pubmed | 2.03e-04 | 29 | 137 | 3 | 17907201 | ||
| Pubmed | 2.03e-04 | 29 | 137 | 3 | 26097038 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDS5B EPRS1 CHD1 NUP155 SUPT5H CIZ1 MKI67 DOCK7 MACF1 PRKDC HERC2 HEATR5B AQR | 2.14e-04 | 1024 | 137 | 13 | 24711643 |
| Pubmed | 2.25e-04 | 30 | 137 | 3 | 19936222 | ||
| Pubmed | Identification of synaptotagmin effectors via acute inhibition of secretion from cracked PC12 cells. | 2.29e-04 | 6 | 137 | 2 | 12860971 | |
| Pubmed | 2.29e-04 | 6 | 137 | 2 | 19812333 | ||
| Pubmed | Critical role for GATA3 in mediating Tie2 expression and function in large vessel endothelial cells. | 2.29e-04 | 6 | 137 | 2 | 19674970 | |
| Interaction | YWHAH interactions | TRAPPC11 DPYSL3 SLC4A7 HDAC5 PPFIBP1 POTEF PTPN21 SHTN1 PARD6B SLC38A2 NEK1 ALMS1 CDCA7 SIPA1L1 DOCK7 FLCN MACF1 HERC1 SUCO AQR TNS3 AHNAK2 | 3.11e-06 | 1102 | 133 | 22 | int:YWHAH |
| Interaction | XAGE1A interactions | 7.19e-06 | 41 | 133 | 5 | int:XAGE1A | |
| Interaction | LOC254896 interactions | 9.14e-06 | 43 | 133 | 5 | int:LOC254896 | |
| Interaction | C2CD4B interactions | 1.03e-05 | 44 | 133 | 5 | int:C2CD4B | |
| Interaction | UCN3 interactions | 1.46e-05 | 23 | 133 | 4 | int:UCN3 | |
| Interaction | CD160 interactions | 1.58e-05 | 48 | 133 | 5 | int:CD160 | |
| Interaction | YWHAG interactions | TRAPPC11 DPYSL3 SLC4A7 HDAC5 PPFIBP1 POTEF PTPN21 SHTN1 PARD6B SLC38A2 NEK1 ALMS1 CDCA7 SIPA1L1 DOCK7 MACF1 PRKDC SUCO CEP97 AQR TNS3 AHNAK2 | 2.20e-05 | 1248 | 133 | 22 | int:YWHAG |
| Interaction | ADAMTS13 interactions | 2.42e-05 | 26 | 133 | 4 | int:ADAMTS13 | |
| Interaction | CIT interactions | PDS5B HIP1 DDX31 HIPK1 HCN1 PCLO CD109 CHD1 ADGRV1 CLPX RALGAPA2 TTC3 SYT10 NUP155 ALMS1 CELSR2 SUPT5H MKI67 MACF1 ELF1 PRKDC HERC1 AQR AHNAK2 | 2.49e-05 | 1450 | 133 | 24 | int:CIT |
| Interaction | SCGB1D1 interactions | 2.90e-05 | 133 | 133 | 7 | int:SCGB1D1 | |
| Interaction | KLK15 interactions | 6.52e-05 | 151 | 133 | 7 | int:KLK15 | |
| Interaction | C2CD4A interactions | 7.66e-05 | 13 | 133 | 3 | int:C2CD4A | |
| Interaction | LPAR4 interactions | 9.07e-05 | 36 | 133 | 4 | int:LPAR4 | |
| Interaction | LAMP1 interactions | TRAPPC11 SLC4A7 ATP13A1 PPFIBP1 NBEA RALGAPA2 NCR3LG1 PARD6B SLC38A2 MET TENM3 KIRREL1 MACF1 AHNAK2 | 9.29e-05 | 644 | 133 | 14 | int:LAMP1 |
| Cytoband | 13q13 | 8.79e-05 | 5 | 137 | 2 | 13q13 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 7.17e-05 | 3 | 89 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 7.17e-05 | 3 | 89 | 2 | 1189 | |
| GeneFamily | Cadherin related | 7.46e-05 | 17 | 89 | 3 | 24 | |
| GeneFamily | ETS transcription factor family | 3.46e-04 | 28 | 89 | 3 | 534 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 8.43e-04 | 9 | 89 | 2 | 1234 | |
| GeneFamily | PDZ domain containing | 9.25e-04 | 152 | 89 | 5 | 1220 | |
| GeneFamily | WD repeat domain containing | 1.86e-03 | 262 | 89 | 6 | 362 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.41e-03 | 15 | 89 | 2 | 26 | |
| GeneFamily | Synaptotagmins | 3.11e-03 | 17 | 89 | 2 | 765 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | EPRS1 TRAPPC11 DPYSL3 POC1A GANC HIPK1 FAT3 PCLO GON4L CHD1 ITGB8 WDR19 NEK1 MRTFB ALMS1 MKI67 PLPBP PRKDC FAM149B1 MLST8 TAPBP | 4.43e-08 | 831 | 132 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 1.22e-05 | 82 | 132 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_100 | 1.38e-05 | 24 | 132 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k3_100 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_100 | 2.73e-05 | 10 | 132 | 3 | gudmap_kidney_P1_CapMes_Crym_k2_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | TRAPPC11 POC1A HIPK1 GON4L CLPX WDR19 MRTFB MKI67 DOCK7 MACF1 PLPBP ELK1 FAM149B1 MLST8 HEATR5B TAPBP | 2.80e-05 | 780 | 132 | 16 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 3.29e-05 | 59 | 132 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_200 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | PPFIBP1 SHTN1 JAML ITGB8 MET ALMS1 MKI67 DOCK7 ARHGAP28 DNASE1L3 TNS3 | 6.46e-05 | 420 | 132 | 11 | GSM538252_500 |
| CoexpressionAtlas | Myeloid Cells, DC.8+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | PPFIBP1 DAPK1 SHTN1 JAML MET ALMS1 MKI67 DOCK7 ARHGAP28 DNASE1L3 TNS3 | 7.18e-05 | 425 | 132 | 11 | GSM538255_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_100 | 8.04e-05 | 37 | 132 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_100 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | A2M HIP1 STAB2 SGIP1 NAPEPLD CD109 GON4L PARD6B NUP155 KIRREL1 ARHGAP28 EGFLAM EIF2AK4 NAIF1 ADPGK AQR | 8.31e-05 | 855 | 132 | 16 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | DPYSL3 NAPEPLD GANC PCLO CAMK1G SIM1 RALGAPA2 ITGB8 CELSR2 CIZ1 HERC2 | 9.19e-05 | 437 | 132 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K2 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100 | 1.12e-04 | 76 | 132 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.63e-04 | 130 | 132 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.Th, CD11b-FITC CD4-PE MHCII-APC CD11c-eFluor780 CD8-eF, Thymus, avg-3 | PPFIBP1 DAPK1 SHTN1 JAML MET ALMS1 MKI67 DOCK7 DNASE1L3 TNS3 | 2.59e-04 | 412 | 132 | 10 | GSM605828_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | DPYSL3 PCLO ADGRV1 SIM1 SHTN1 ITGB8 PARD6B CELSR2 MACF1 MUC4 CEP97 | 2.71e-04 | 495 | 132 | 11 | Facebase_RNAseq_e10.5_Olfactory Pit_500 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_100 | 2.89e-04 | 93 | 132 | 5 | gudmap_kidney_adult_Podocyte_MafB_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.92e-04 | 204 | 132 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 3.07e-04 | 146 | 132 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 3.18e-04 | 147 | 132 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 3.68e-04 | 98 | 132 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 3.94e-04 | 153 | 132 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | EPRS1 DPYSL3 SLC4A7 FAT3 PCLO CHD1 ADGRV1 SIM1 ITGB8 WDR19 NEK1 ALMS1 CELSR2 MKI67 PRKDC CEP97 | 4.30e-04 | 989 | 132 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 4.37e-04 | 156 | 132 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 4.72e-04 | 221 | 132 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K5 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | A2M DPYSL3 SGIP1 FAT3 SLC38A2 HMCN1 TENM3 MACF1 ARHGAP28 TNXB | 3.26e-10 | 187 | 136 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.28e-10 | 200 | 136 | 10 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.88e-09 | 181 | 136 | 9 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-09 | 182 | 136 | 9 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-09 | 187 | 136 | 9 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 7.45e-09 | 190 | 136 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.80e-09 | 191 | 136 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.16e-09 | 192 | 136 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-09 | 196 | 136 | 9 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.07e-08 | 198 | 136 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.11e-08 | 199 | 136 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-08 | 200 | 136 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-08 | 200 | 136 | 9 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-08 | 200 | 136 | 9 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.70e-08 | 183 | 136 | 8 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-07 | 184 | 136 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-07 | 184 | 136 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-07 | 184 | 136 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.40e-07 | 192 | 136 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.46e-07 | 193 | 136 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-07 | 195 | 136 | 8 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-07 | 195 | 136 | 8 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-07 | 196 | 136 | 8 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.64e-07 | 196 | 136 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.71e-07 | 197 | 136 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-07 | 197 | 136 | 8 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.71e-07 | 197 | 136 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.78e-07 | 198 | 136 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-07 | 200 | 136 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.41e-07 | 170 | 136 | 7 | e20568c8f3f17d94de78229617eb2f7e4c5af2bc | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 174 | 136 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 176 | 136 | 7 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 181 | 136 | 7 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-06 | 183 | 136 | 7 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.66e-06 | 185 | 136 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.72e-06 | 186 | 136 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.84e-06 | 188 | 136 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-06 | 188 | 136 | 7 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-06 | 189 | 136 | 7 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-06 | 190 | 136 | 7 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.98e-06 | 190 | 136 | 7 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-06 | 191 | 136 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 2.12e-06 | 192 | 136 | 7 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.19e-06 | 193 | 136 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.19e-06 | 193 | 136 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.35e-06 | 195 | 136 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.35e-06 | 195 | 136 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 195 | 136 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 195 | 136 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.51e-06 | 197 | 136 | 7 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.51e-06 | 197 | 136 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.60e-06 | 198 | 136 | 7 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.60e-06 | 198 | 136 | 7 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 199 | 136 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.69e-06 | 199 | 136 | 7 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.69e-06 | 199 | 136 | 7 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Parenchymal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-06 | 200 | 136 | 7 | 0e648e9eb96c83a94505d07323785a7a40997eb0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-06 | 200 | 136 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 2.78e-06 | 200 | 136 | 7 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 2.78e-06 | 200 | 136 | 7 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-06 | 153 | 136 | 6 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 169 | 136 | 6 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-05 | 169 | 136 | 6 | 481e611b5fface58f1630f206c0b04fb54e24011 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.64e-05 | 175 | 136 | 6 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.70e-05 | 176 | 136 | 6 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.70e-05 | 176 | 136 | 6 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 177 | 136 | 6 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.81e-05 | 178 | 136 | 6 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 1.81e-05 | 178 | 136 | 6 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 181 | 136 | 6 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-05 | 181 | 136 | 6 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 181 | 136 | 6 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.99e-05 | 181 | 136 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 183 | 136 | 6 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.18e-05 | 184 | 136 | 6 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-05 | 186 | 136 | 6 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-05 | 186 | 136 | 6 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 186 | 136 | 6 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.32e-05 | 186 | 136 | 6 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 2.39e-05 | 187 | 136 | 6 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.39e-05 | 187 | 136 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.46e-05 | 188 | 136 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 189 | 136 | 6 | e60a3d6aa84788c29f23439f1c747431ea581bc3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 189 | 136 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 189 | 136 | 6 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.54e-05 | 189 | 136 | 6 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.54e-05 | 189 | 136 | 6 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.61e-05 | 190 | 136 | 6 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-05 | 190 | 136 | 6 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.61e-05 | 190 | 136 | 6 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 190 | 136 | 6 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 2.69e-05 | 191 | 136 | 6 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.69e-05 | 191 | 136 | 6 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.69e-05 | 191 | 136 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 2.77e-05 | 192 | 136 | 6 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.77e-05 | 192 | 136 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.77e-05 | 192 | 136 | 6 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.77e-05 | 192 | 136 | 6 | 0afb9dbe468e0be442c326e11c5fc0f699b32f23 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.85e-05 | 193 | 136 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.85e-05 | 193 | 136 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 1.57e-05 | 189 | 133 | 8 | 6649_DN | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.70e-05 | 191 | 133 | 8 | 4168_DN | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.76e-05 | 192 | 133 | 8 | 849_DN | |
| Drug | ikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 1.83e-05 | 193 | 133 | 8 | 866_DN | |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; PC3; HG-U133A | 1.97e-05 | 195 | 133 | 8 | 1932_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.12e-05 | 197 | 133 | 8 | 3931_DN | |
| Drug | Praziquantel [55268-74-1]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.12e-05 | 197 | 133 | 8 | 5874_DN | |
| Drug | Nitrocaramiphen hydrochloride; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.12e-05 | 197 | 133 | 8 | 7464_UP | |
| Drug | Amidopyrine [58-15-1]; Down 200; 17.2uM; PC3; HT_HG-U133A | 2.12e-05 | 197 | 133 | 8 | 2060_DN | |
| Drug | Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.20e-05 | 198 | 133 | 8 | 6800_UP | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; HL60; HG-U133A | 2.28e-05 | 199 | 133 | 8 | 2039_UP | |
| Disease | Usher syndrome type 2C (implicated_via_orthology) | 1.96e-05 | 2 | 131 | 2 | DOID:0110839 (implicated_via_orthology) | |
| Disease | Tinnitus, response to cisplatin | 3.74e-05 | 15 | 131 | 3 | GO_0072718, HP_0000360 | |
| Disease | Adenoid Cystic Carcinoma | 8.58e-05 | 100 | 131 | 5 | C0010606 | |
| Disease | mucositis (biomarker_via_orthology) | 1.94e-04 | 5 | 131 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | factor VIII measurement, von Willebrand factor measurement | 2.31e-04 | 27 | 131 | 3 | EFO_0004629, EFO_0004630 | |
| Disease | glucagon measurement, glucose tolerance test | 2.90e-04 | 6 | 131 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | cortical surface area measurement | ZNF438 DCHS2 DPYSL3 PPFIBP1 FAT3 DAPK1 ADGRV1 SHTN1 CLSTN1 ITGB8 SLC38A2 VCAN MACF1 ELF2 ARHGAP28 TNXB | 3.16e-04 | 1345 | 131 | 16 | EFO_0010736 |
| Disease | Ischemic stroke, von Willebrand factor measurement | 3.18e-04 | 30 | 131 | 3 | EFO_0004629, HP_0002140 | |
| Disease | QRS duration | 3.83e-04 | 298 | 131 | 7 | EFO_0005055 | |
| Disease | tumor necrosis factor ligand superfamily member 6, soluble form measurement | 4.05e-04 | 7 | 131 | 2 | EFO_0020797 | |
| Disease | neutrophil count | SGIP1 ATP13A1 SYT6 JAML FANCA MET CRCP COQ8A SUPT5H KIRREL1 PRKDC FCRL5 TNXB NAIF1 TNS3 GABPB1 | 4.26e-04 | 1382 | 131 | 16 | EFO_0004833 |
| Disease | hepatocyte growth factor-like protein measurement | 6.44e-04 | 38 | 131 | 3 | EFO_0008154 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 6.90e-04 | 9 | 131 | 2 | C3502809 | |
| Disease | Asthma, Occupational | 8.60e-04 | 10 | 131 | 2 | C0264423 | |
| Disease | N6-acetyllysine measurement | 8.60e-04 | 10 | 131 | 2 | EFO_0800036 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 8.65e-04 | 42 | 131 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | Adenocarcinoma of large intestine | 8.99e-04 | 96 | 131 | 4 | C1319315 | |
| Disease | sunburn | 8.99e-04 | 96 | 131 | 4 | EFO_0003958 | |
| Disease | Malignant neoplasm of breast | ZNF438 CD109 TACC2 SIM1 TTC3 EPG5 SIPA1L1 MKI67 MACF1 FCRL5 HERC2 ENPEP DNASE1L3 | 1.01e-03 | 1074 | 131 | 13 | C0006142 |
| Disease | Copper-Overload Cirrhosis | 1.05e-03 | 11 | 131 | 2 | C1876165 | |
| Disease | Malignant neoplasm of salivary gland | 1.06e-03 | 45 | 131 | 3 | C0220636 | |
| Disease | neurotic disorder | 1.09e-03 | 101 | 131 | 4 | EFO_0004257 | |
| Disease | homocysteine measurement | 1.13e-03 | 46 | 131 | 3 | EFO_0004578 | |
| Disease | Salivary Gland Neoplasms | 1.20e-03 | 47 | 131 | 3 | C0036095 | |
| Disease | hair colour measurement, hair morphology measurement | 1.25e-03 | 12 | 131 | 2 | EFO_0007821, EFO_0007822 | |
| Disease | pulse pressure measurement | ZNF438 HIP1 SLC4A7 SGIP1 FAT3 NBEA HNF4G NCR3LG1 SYT10 MET CDCA7 EIF2AK4 ENPEP CEP97 TNS3 | 1.33e-03 | 1392 | 131 | 15 | EFO_0005763 |
| Disease | cervical carcinoma | 1.34e-03 | 182 | 131 | 5 | EFO_0001061 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 1.48e-03 | 13 | 131 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | TPE interval measurement | 1.61e-03 | 52 | 131 | 3 | EFO_0004644 | |
| Disease | Beta blocking agent use measurement | 1.70e-03 | 114 | 131 | 4 | EFO_0009929 | |
| Disease | Prostatic Neoplasms | 1.76e-03 | 616 | 131 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.76e-03 | 616 | 131 | 9 | C0376358 | |
| Disease | Carcinoma, Granular Cell | 1.81e-03 | 116 | 131 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.81e-03 | 116 | 131 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.81e-03 | 116 | 131 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.81e-03 | 116 | 131 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.81e-03 | 116 | 131 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 1.81e-03 | 116 | 131 | 4 | C0001418 | |
| Disease | urate measurement, bone density | 1.82e-03 | 619 | 131 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | triglycerides in medium VLDL measurement | 1.90e-03 | 55 | 131 | 3 | EFO_0022155 | |
| Disease | keratinocyte carcinoma | 1.93e-03 | 118 | 131 | 4 | EFO_0010176 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 1.93e-03 | 118 | 131 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 1.98e-03 | 15 | 131 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | N-acetylmethionine measurement | 1.98e-03 | 15 | 131 | 2 | EFO_0021427 | |
| Disease | brain connectivity measurement | 2.12e-03 | 400 | 131 | 7 | EFO_0005210 | |
| Disease | Schizoaffective disorder-bipolar type | 2.25e-03 | 16 | 131 | 2 | EFO_0009965 | |
| Disease | Idiopathic pulmonary arterial hypertension | 2.25e-03 | 16 | 131 | 2 | C3203102 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.31e-03 | 206 | 131 | 5 | C0152013 | |
| Disease | Familial primary pulmonary hypertension | 2.55e-03 | 17 | 131 | 2 | C0340543 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.59e-03 | 128 | 131 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.59e-03 | 128 | 131 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.59e-03 | 128 | 131 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.59e-03 | 128 | 131 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.59e-03 | 128 | 131 | 4 | C0007134 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 2.86e-03 | 18 | 131 | 2 | HP_0002373 | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.92e-03 | 64 | 131 | 3 | DOID:4947 (is_marker_for) | |
| Disease | cholesterol in large VLDL measurement | 3.06e-03 | 65 | 131 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 3.06e-03 | 65 | 131 | 3 | EFO_0022230 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 3.11e-03 | 801 | 131 | 10 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | myeloid white cell count | DNAH10 ATP13A1 JAML PRX MET CRCP SUPT5H KIRREL1 FCRL5 NAIF1 TNS3 | 3.12e-03 | 937 | 131 | 11 | EFO_0007988 |
| Disease | skin sensitivity to sun | 3.18e-03 | 19 | 131 | 2 | EFO_0004795 | |
| Disease | blood metabolite measurement | 3.18e-03 | 19 | 131 | 2 | EFO_0005664 | |
| Disease | hydrocephalus (implicated_via_orthology) | 3.18e-03 | 19 | 131 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | total lipids in small VLDL | 3.33e-03 | 67 | 131 | 3 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 3.33e-03 | 67 | 131 | 3 | EFO_0022175 | |
| Disease | free cholesterol in large VLDL measurement | 3.47e-03 | 68 | 131 | 3 | EFO_0022265 | |
| Disease | mean corpuscular hemoglobin concentration | RAD52 PDS5B POTEF FAAP20 GON4L CLPX CDCA7 MACF1 ELF1 EIF2AK4 PRKDC TNS3 | 3.83e-03 | 1105 | 131 | 12 | EFO_0004528 |
| Disease | coronary artery calcification | 4.05e-03 | 450 | 131 | 7 | EFO_0004723 | |
| Disease | cortical thickness | A2M ZNF438 PDS5B PPFIBP1 FAT3 TACC2 ADGRV1 SHTN1 HNF4G VCAN DOCK7 MACF1 | 4.05e-03 | 1113 | 131 | 12 | EFO_0004840 |
| Disease | Hepatitis, Chronic | 4.26e-03 | 22 | 131 | 2 | C0019189 | |
| Disease | Chronic active hepatitis | 4.26e-03 | 22 | 131 | 2 | C0520463 | |
| Disease | Chronic Persistent Hepatitis | 4.26e-03 | 22 | 131 | 2 | C0149519 | |
| Disease | Cryptogenic Chronic Hepatitis | 4.26e-03 | 22 | 131 | 2 | C0524611 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.35e-03 | 148 | 131 | 4 | C0279702 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 4.41e-03 | 74 | 131 | 3 | EFO_0022280 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PHPLVTSTDIVLTIT | 251 | P21399 | |
| TITAVHPEIISVLLD | 826 | Q9HCE0 | |
| DPTSIHVVVFSLEEP | 831 | P53355 | |
| VVTSISDIPTGIPVH | 281 | Q9BRR6 | |
| PVTHVSVTLDGIPEV | 136 | P32519 | |
| HSVPLSRDIPTTEEV | 86 | Q63HQ2 | |
| HIPSISVDGLSTPVV | 406 | P19419 | |
| SHVPPTTLEDIVAKE | 1256 | P13611 | |
| PVVVPLHSLDEKTLV | 501 | O76031 | |
| HGATVVPIVSVLAPE | 1526 | Q9P2K8 | |
| HFTSPEVVIPLKVIS | 36 | Q9UKJ8 | |
| SLHQEVSVLVPDPTV | 261 | Q9UIF9 | |
| EVTPVSSIPVETHRA | 556 | Q9HD20 | |
| TTMIIDHVVPEPESS | 101 | Q14195 | |
| IHISVSEPIIPFRET | 681 | Q7Z2Z2 | |
| TLPASSVPHITVEEE | 1721 | Q8WXG9 | |
| HLTEETLKVTAIPEP | 546 | Q8TCU4 | |
| TEEAKTLIVEPHVIP | 771 | O60306 | |
| PIINTPVVSISVHDD | 2276 | Q9HCU4 | |
| HPFAVVPSTATVVIV | 851 | O94985 | |
| VHITASGEPVPISEE | 1391 | O14646 | |
| TIALLEIPLTVTHPV | 1106 | P01023 | |
| VPVPLATTAEEATHQ | 551 | Q149M9 | |
| DPSNLEHLITPLVTI | 756 | Q9NTI5 | |
| ESIEPDVVKPHLTST | 186 | P57729 | |
| VTHSTPVTVSEPLLE | 296 | P43351 | |
| PVSSIIDVDILPETH | 141 | Q9BYG5 | |
| VSPIIIVHEIDEDSP | 256 | P48050 | |
| IPVEEIHSPFTTILL | 476 | P0C881 | |
| IPVEEIHSPFTTILL | 476 | B2RC85 | |
| LLPHVVPGTTEDTLI | 21 | Q99102 | |
| VAPEEHPVLLTEATL | 796 | A5A3E0 | |
| EPVSVPQTLTSTLEH | 351 | Q8NBT0 | |
| SVTLPLETLVSPHEE | 691 | Q8NEZ4 | |
| ISHEINPSAIVDSPV | 856 | Q96PY6 | |
| IPPHVLSSEFAVIVE | 426 | Q8NFG4 | |
| TVSPELILDHEVPSL | 46 | Q6NZ36 | |
| VPEEFHTTILQVSIP | 396 | Q86W92 | |
| IISLPSTTEIHPVAL | 141 | Q69YI7 | |
| LPAPAVEHIVVTAAD | 76 | Q86Z02 | |
| TVDVATPSVHEPVLF | 3326 | O95714 | |
| HPIEISEDVITGPTI | 186 | Q68D85 | |
| PDTVTIHAATPQFII | 171 | Q06547 | |
| DVIHTAIEVVSSLPP | 191 | Q15751 | |
| PAIHITAATDPKVEI | 2686 | Q9UPA5 | |
| PPVHTETVSKIVDSV | 4036 | Q5CZC0 | |
| IPEPEVSITSAHIDP | 166 | Q9BVC4 | |
| ITPRHVIVLSAPDTV | 156 | Q96MA6 | |
| AHAVTLAITKPVTVP | 2861 | Q9Y6V0 | |
| AVSLSVTVPVSHPVL | 461 | Q96RD9 | |
| TILAVIKVEPSLHEP | 46 | Q8NH63 | |
| LLVHPVTEPKATTVD | 721 | Q8TET4 | |
| SNPEVTVALPVTTLH | 446 | Q9ULH7 | |
| VPFPHEDILVASIVS | 876 | O94854 | |
| SSHPIIVTVTTPDEI | 456 | Q07075 | |
| IPTDVEVLPTETEIH | 426 | P46013 | |
| LDTVHVDPVIRESTP | 106 | Q86UT6 | |
| TILVVVATEPVLHKP | 46 | Q8NH57 | |
| AIPESLKQHVTVVPS | 476 | Q9H8H2 | |
| PVSVLLHPVSTAVLE | 1271 | Q2PPJ7 | |
| TLVHADQISTPETPL | 361 | Q14541 | |
| PDVHEEVLGVVPITT | 261 | Q14764 | |
| LNKDHIPITDSPVVV | 476 | O75694 | |
| ETEITLHVQEPPTVE | 1251 | Q96RW7 | |
| PEITITEAPVLDHSV | 351 | Q96NX5 | |
| LPVAHSLQEVSEPLT | 611 | Q16825 | |
| KPLDHETQPVVVLTV | 936 | Q6V1P9 | |
| VDSIEYPSVHVIIPT | 96 | P26012 | |
| NVETIPDLPEHTTII | 561 | Q9UKF2 | |
| HLGEIPITVTALSPT | 826 | Q6YHK3 | |
| SPVPVGIDVHVESID | 81 | A8MPY1 | |
| EVSTLISRPHPTVGE | 796 | O60741 | |
| VLTLLLTVPPSHTEV | 981 | Q9P2D3 | |
| VKDFVIIPLHTTPET | 146 | Q13609 | |
| IIPLHTTPETSVKEI | 151 | Q13609 | |
| HTTVPLTEAVDPVDL | 46 | Q96N67 | |
| LVPVETRASLIPEHS | 316 | Q8IW35 | |
| TAPAETSHPVLLTVE | 126 | O15360 | |
| VIEESTHKPTAIPLE | 3541 | Q8TDW7 | |
| THKPTAIPLEIFIVT | 3546 | Q8TDW7 | |
| VTTPAIRHISAEVVP | 431 | Q3T8J9 | |
| PEIVDELCSPHVLTT | 431 | Q8NI60 | |
| THVVVVSAPSAIALP | 566 | Q15723 | |
| KETSIELDVHHPPTV | 211 | Q96J84 | |
| ELDVHHPPTVTLSIE | 216 | Q96J84 | |
| VELVPHPETAPTTVD | 156 | Q9Y2S2 | |
| PEEPITVAHIVVEAA | 111 | Q66K89 | |
| TGEPIETSPVIHLVT | 311 | Q66K89 | |
| PRTSLHSIPVTVEVK | 21 | Q9UQL6 | |
| VVDINDHIPIFVSTP | 641 | Q9NYQ7 | |
| VPLFHTETILTAPEI | 891 | Q8IVF4 | |
| TETILTAPEIILHPN | 896 | Q8IVF4 | |
| VFVDVIHTDSSPIVP | 216 | P54317 | |
| LLPPIGTAEVEHVST | 471 | Q96BN6 | |
| PAHISPAIPVIITAV | 51 | P41145 | |
| PIVVTLVDDETPHLT | 1296 | P0C091 | |
| LDSHPVSPEVIVEHT | 481 | P08581 | |
| AVKISHTSPDIPAEV | 131 | Q5T7P8 | |
| AETTHALPIPVICVT | 611 | P07814 | |
| SHLVLPVQPVSSIEE | 451 | Q8NFQ8 | |
| LLHTVTSILPAEPEA | 116 | O75575 | |
| VSPASDDIPTVVIHP | 336 | Q9Y6M7 | |
| TIVLHVSPEEPRTLV | 246 | Q86YT9 | |
| TLPHLTIPAVVTVTC | 2606 | Q8NFP9 | |
| ASALSEHISPVVVIP | 301 | O00291 | |
| EHISPVVVIPAEASS | 306 | O00291 | |
| TSVTVKVVIIPPHDD | 1016 | O43166 | |
| VAVGHSLPPSAVTEI | 211 | P81133 | |
| AEPVVVLDPVSTHEP | 576 | A0MZ66 | |
| FPSHIVPILTSTVIE | 1186 | Q8NEZ3 | |
| KVVSISSEHLEPITP | 1021 | O00267 | |
| ITLVQEPPPVSTVVH | 1336 | Q68CZ2 | |
| LPPSETIAIVEHINA | 156 | O94903 | |
| VHVSAPKVEADVSLP | 3826 | Q8IVF2 | |
| SSVTLPHIIRPVEEI | 231 | Q9BWT1 | |
| VSLLAPEQTPVVVHV | 471 | Q9ULV3 | |
| STVSLEPAPVTVHID | 1331 | A0JNW5 | |
| EPAPVTVHIDHLVVE | 1336 | A0JNW5 | |
| PIITTVITLPHVIVE | 996 | Q7Z392 | |
| IELVPEHQTVPVSIG | 21 | A0JD36 | |
| ATVVPTHLAAAVPEV | 156 | Q15257 | |
| TVPVVIFPIRSSVTH | 386 | Q96QD8 | |
| EHVTPELTPREKVVS | 321 | Q9BQI5 | |
| SVAILETIPVLPVHS | 241 | Q9P2N2 | |
| HVGVPSLTLPSVELD | 846 | Q9BXM0 | |
| TVVLTVLTHTPAPRV | 156 | O15533 | |
| AVPIDTEVTQTPKHL | 16 | A0A577 | |
| IILDPETAHPNLIVS | 296 | A6NK02 | |
| VVPVEGHERSVTVTP | 1716 | P22105 | |
| EVIPESTSAVTNIPH | 1446 | P53804 | |
| LSVITDPIHTPVTLF | 1766 | Q8WWQ8 | |
| DSPIIPETQVLHEET | 981 | Q9P273 | |
| EVKVSTQDPPEVTHI | 611 | P08922 | |
| PETPPVISAVVHATD | 2456 | O95359 | |
| LIHAPSVVAKTEQEP | 381 | A8MT19 | |
| PVVETLPTVDLHEES | 106 | Q9UBS9 | |
| AIEPAIKISHTSPDI | 126 | Q6XYQ8 | |
| TVPEVYTPVLEHLVV | 426 | P78527 | |
| TVEIKEDTPHTALVP | 531 | O60290 | |
| TCTVTPEAPREVLLH | 571 | Q86VR7 | |
| PVSVAHLLSPVATEL | 71 | Q9BT76 | |
| QEFPEITILTTEVHP | 281 | Q96BW1 | |
| LKEVHRVVISTEPAP | 586 | Q7Z4V0 | |
| THITPFPIIIIQEES | 146 | Q9H3S4 | |
| TISELPPIDAVLISH | 171 | Q6IQ20 |